Clinical Characterisation of Severe Hypoglycaemia

Abstract

Aim

To determine the clinical characteristics of severe hypoglycaemia (SH) in a nonselected German population. SH was defined as an event requiring intravenous glucose or glucagon injection.

Methods

The prospective population-based study screened sensitively for SH in a region with 200 000 inhabitants between 1997 and 2000. All 30 768 patients who presented to the regional central hospital emergency department, and 6631 (85 %) of 7804 patients attended by the emergency medical service in the region were given an initial blood glucose test to detect atypical hypoglycaemia.

Results

Altogether, 264 cases of SH were registered, which occurred either spontaneously (n = 14; 5 %), in subjects with type 1 (n = 92; 35 %) or type 2 diabetes (n = 148; 56 %), or in subjects with a non-classified form of diabetes (n = 10; 4 %). On the basis of the estimated local number of diabetic patients the annual rate of SH was 1.5 episodes per 100 patients in insulin-treated type 2 diabetics compared with a rate of 0.4 episodes per 100 patients for the overall group of type 2 diabetic patients. Nocturnal hypoglycaemia accounted for 44 % of episodes in patients with type 1 diabetes on intensified therapy but for only 25 % in patients with type 2 diabetes. 26 % of the hypoglycaemic individuals with type 1 diabetes had an impaired awareness of hypoglycaemia and thus recurrent hypoglycaemic episodes. Irrespective of the treatment, the most frequent contributing factors for SH in type 2 diabetic patients were advanced age (76 ± 12 years), multimorbidity (3.6 ± 2.6 concomitant diseases) - in particular renal impairment (54 % [80/148]) - and polypharmacy (4 ± 2.7 concomitant drugs). 34 % (50/148) of the subjects with type 2 diabetes lived in nursing homes or were cared for by a home nursing service. With standardised treatment zero mortality of SH in diabetic patients was achieved, only one non-diabetic died due to hepatic failure.

Conclusion

In elderly, multimorbid patients approaching the insulin-deficient end of the spectrum of type 2 diabetes the risk of developing SH increases considerably, nearing that in patients with type 1 diabetes. In order to avoid SH in geriatric patients, the treatment targets should be defined critically, taking into account individual quality of life and life expectancy. Hypoglycaemia unawareness is a major risk factor for SH in type 1 diabetes.

Key words

Severe hypoglycaemia - type 1 diabetes - type 2 diabetes

References

• 1 Akram K, Pedersen-Bjergaard U, Pramming S, Borch-Johansen, Thorsteinsson B. Similar risk of severe hypoglycaemia in insulin-treated type 2 diabetes and type 1 diabetes with normal awareness.  Diabetologia. 2002;  45 (Suppl 2) A78-A79
• 2 Allicar M, Megas F, Houzard S, Baroux A, Le Thai F, Augendre-Ferrante B. Frequency and costs of hospital stays for hypoglycemia in France in 1995.  Presse Med. 2000;  29 837-853
• 3 Bachmann W, Löbe A, Lacher F. Medikamentös bedingte Hypoglykämien bei Typ-II-Diabetes.  Diabetes und Stoffwechsel. 1995;  4 83-89
• 4 Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients.  Arch Int Med. 1999;  159 281-284
• 5 Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycemia.  Diabetologia. 1997;  40 926-932
• 6 Clarke W L, Cox D J, Gonder-Frederick L A, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM.  Diabetes Care. 1995;  18 517-522
• 7 Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine.  Nephron. 1976;  16 31-41
• 8 Cryer P E. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II diabetes.  Diabetologia. 2002;  45 937-948
• 9 Cull C, Wright A, Macleod K, Holman R. Hypoglycaemia in patients with Type 2 diabetes in the UKPDS.  Diabetologia. 2001;  44 (Suppl 1) A832
• 10 DCCT . Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial: Diabetes Control and Complications Trial Research Group.  Am J Med. 1991;  90 450-459
• 11 DCCT . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.  New Engl J Med. 1993;  329 977-986
• 12 Gold A E, MacLeod K M, Frier B M. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia.  Diabetes Care. 1994;  17 697-703
• 13 Gossain V V, Carella M J, Rovner D R. Management of diabetes in the elderly: a clinical perspective.  J Assoc Acad Minor Phys. 1994;  5 22-31
• 14 Harris G, Diment A, Sulway M, Wilkinson M. Glucagon administration - underevaluated and undertaught.  Pract Diab Int. 2001;  18 22-25
• 15 Hart S, Frier B. Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission.  Q J Med. 1998;  91 505-510
• 16 Hauner H. Verbreitung des Diabetes mellitus in Deutschland.  Dtsch Med Wochenschr. 1998;  123 777-782
• 17 Heller S, Chapman J, McLoud J, Ward J. Unreliability of reports of hypoglycaemia by diabetic patients.  Brit Med J. 1995;  310 440
• 18 Hepburn D A, Patrick A W, Eadington D W, Ewing D J, Frier B M. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy.  Diabet Med. 1990;  7 711-717
• 19 Holstein A, Kühne D, Elsing H-G, Thiessen E, Plaschke A, Widjaja A, Vogel M Y, Egberts E H. Practicality and accuracy of prehospital rapid venous blood glucose determination.  Am J Emerg Med. 2000;  18 690-694
• 20 Holstein A, Plaschke A, Egberts E-H. Lower incidence of severe hypoglycaemia in Type 2 diabetic patients treated with glimepiride versus glibenclamide.  Diab Metabol Res Rev. 2001;  17 467-473
• 21 Holstein A, Plaschke A, Egberts E-H. Incidence and costs of severe hypoglycemia.  Diabetes Care. 2002;  25 2109-2110
• 22 Holstein A, Plaschke A, Vogel Y-M, Egberts E-H. Prehospital management of diabetic emergencies - a population-based intervention study.  Acta Anaesthesiol Scand. 2003;  47 610-615
• 23 Laing S, Swerdlow A, Slater S, Botha J, Burden A, Waugh N, Smith A W, Hill R D, Bingley P J, Patterson C C, Qiao Z, Keen H. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus.  Diabet Med. 1999;  16 459-465
• 24 Miller C D, Phillips L S, Ziemer D C, Gallina D L, Cook C B, El-Kebbi I M. Hypoglycemia in patients with type 2 diabetes mellitus.  Arch Int Med. 2001;  161 1653-1659
• 25 Mooradian A D, Kalis J, Nugent C A. The nutritional status of ambulatory elderly type 2 diabetic patients.  Age. 1990;  13 87-89
• 26 Mühlhauser I, Berger M, Sonnenberg G, Koch J, Jörgens V, Schernthaner G, Scholz V, Padagogin D. Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus.  Diabetes Care. 1985;  8 268-273
• 27 Palitzsch K-D, Nusser J, Arndt H, Enger I, Zietz B, Hugl S, Cuk A, Schaffler A, Buttner R, Frick E, Rath H, Schölmerich J. und die Diabetomobil-Studiengruppe . Die Prävalenz des Diabetes mellitus wird in Deutschland deutlich unterschätzt - eine bundesweite epidemiologische Studie auf der Basis einer HbA_1c-Analyse.  Diabetes und Stoffwechsel. 1999;  8 189-200
• 28 Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients.  Diabet Med. 1991;  8 217-222
• 29 Riddle M, Schneider J. Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.  Diabetes Care. 1998;  21 1052-1057
• 30 Segel S A, Paramore D S, Cryer P E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.  Diabetes. 2002;  51 724-733
• 31 ter Braak E W, Appelman A M, van de Laak M, Stolk R P, van Haeften T W, Erkelens D W. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.  Diabetes Care. 2000;  23 1467-1471
• 32 UKPDS33 . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).  Lancet. 1998;  352 837-853
• 33 Yki-Järvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus.  Ann Intern Med. 1999;  130 389-396